ePrints

Cholinesterase inhibitors reduce cortical A beta in dementia with Lewy bodies

Lookup NU author(s): Carein Todd, Professor Ian McKeith, Professor John O'Brien, Emeritus Professor Elaine Perry

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Cholinesterase inhibitors (ChEls) are effective symptomatic treatments in dementia with Lewy bodies (DLB), although effects on pathologic mechanisms are unknown. In the first human autopsy study examining the impact of ChEl treatment on brain pathology, we compared treated patients with DLB with matched untreated patients for cortical beta-amyloid (A beta) and tau pathologies. Treated patients with DLB had significantly less parenchymal A beta deposition, which is relevant to disease management and treatment of dementia patients using ChEl.

Publication metadata

Author(s): Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK

Publication type: Article

Publication status: Published

Journal: Neurology

Year: 2007

Volume: 68

Issue: 20

Pages: 1726-1729

ISSN (print): 0028-3878

ISSN (electronic): 1526-632X

Publisher: Lippincott Williams & Wilkins

URL: http://dx.doi.org/10.1212/01.wnl.0000261920.03297.64

DOI: 10.1212/01.wnl.0000261920.03297.64

Altmetrics

Funding

Share